Jose Manuel Otero insider trades

Open-market stock purchases and sales by Jose Manuel Otero, Chief Operating Officer at Lexeo Therapeutics, Inc, from SEC Form 4 filings since Jun 12, 2024.

Recent trades

DateStockTradeValue
Sep 24, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
Sep 14, 2026LXEO Lexeo Therapeutics, IncBought (not open market)$5.6K
Aug 18, 2026LXEO Lexeo Therapeutics, IncSold$6.5K
Jul 1, 2026LXEO Lexeo Therapeutics, IncSold$20.9K
Jun 29, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
May 18, 2026LXEO Lexeo Therapeutics, IncSold$6.6K
Mar 13, 2026LXEO Lexeo Therapeutics, IncBought (not open market)$15.7K
Feb 18, 2026LXEO Lexeo Therapeutics, IncSold$19.3K
Feb 4, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
Feb 4, 2026LXEO Lexeo Therapeutics, IncBought (not open market)—
Nov 18, 2025LXEO Lexeo Therapeutics, IncSold$6.7K

Companies traded

  • LXEO Lexeo Therapeutics, Inc: 9 sales, last Sep 24, 2026

Get free alerts when Jose Manuel Otero files a new trade →